Zonalta’s Impact on Protein Kinase C in the Management of Bipolar Disorder
Zonalta, a promising intervention for Bipolar Disorder, targets Protein Kinase C (PKC) to regulate cellular processes influencing mood. By modulating PKC activity, Zonalta aims to restore balance in neurotransmitter signaling, offering a unique and targeted approach to managing the complex biochemical imbalances associated with Bipolar Disorder.
Visit for More: https://medium.com/@zonatla61/....zonaltas-impact-on-p
Like
Comment
Share
